EBAC

European Biotech Acquisition Corp. Class A Ordinary Shares
EBAC

Delisted

EBAC was delisted on the 2nd of March, 2023.

Back to rankings

45 hedge funds and large institutions have $69.6M invested in European Biotech Acquisition Corp. Class A Ordinary Shares in 2021 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 2 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more first-time investments, than exits

New positions opened: | Existing positions closed:

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding: →

Holders
45
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$8K
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$7.49M
2
+$4.5M
3
+$1.6M
4
AMH
Apollo Management Holdings
New York
+$967K
5
Marshall Wace
Marshall Wace
United Kingdom
+$852K

Top Sellers

1
-$1.43M
2
-$87.3K
3
-$4K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$710K
27
$637K
28
$528K
29
$485K
30
$439K
31
$388K
32
$383K
33
$340K
34
$339K
35
$262K
36
$190K
37
$172K
38
$106K
39
$100K
40
$97K
41
$68K
42
$23K
43
$19K
44
$15K
45
$2K
46
–
47
–
1
2